WO2016048007A8 - D-갈락토오스를 포함하는 쿼럼센싱 저해제 - Google Patents
D-갈락토오스를 포함하는 쿼럼센싱 저해제 Download PDFInfo
- Publication number
- WO2016048007A8 WO2016048007A8 PCT/KR2015/009948 KR2015009948W WO2016048007A8 WO 2016048007 A8 WO2016048007 A8 WO 2016048007A8 KR 2015009948 W KR2015009948 W KR 2015009948W WO 2016048007 A8 WO2016048007 A8 WO 2016048007A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- galactose
- quorum sensing
- inhibitor containing
- sensing inhibitor
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
D-galactose의 쿼럼센싱 저해 및 /또는 세균성 구강 질환의 예방 및/또는 치료에 사용하기 위한 용도에 관한 것으로, D-galactose를 포함하는 쿼럼센싱 저해제 및 세균성 구강 질환의 예방 및/또는 치료용 조성물이 제공된다.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020167019725A KR101870239B1 (ko) | 2014-09-24 | 2015-09-22 | D-갈락토오스를 포함하는 쿼럼센싱 저해제 |
CN201580050473.5A CN106794191A (zh) | 2014-09-24 | 2015-09-22 | 含d‑半乳糖的群体感应抑制剂 |
KR1020177008824A KR101951024B1 (ko) | 2014-09-24 | 2015-09-22 | D-갈락토오스를 포함하는 쿼럼센싱 저해제 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462054431P | 2014-09-24 | 2014-09-24 | |
US62/054,431 | 2014-09-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016048007A1 WO2016048007A1 (ko) | 2016-03-31 |
WO2016048007A8 true WO2016048007A8 (ko) | 2016-09-01 |
Family
ID=55524745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2015/009948 WO2016048007A1 (ko) | 2014-09-24 | 2015-09-22 | D-갈락토오스를 포함하는 쿼럼센싱 저해제 |
Country Status (4)
Country | Link |
---|---|
US (2) | US10292993B2 (ko) |
KR (2) | KR101870239B1 (ko) |
CN (1) | CN106794191A (ko) |
WO (1) | WO2016048007A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3654769A1 (en) * | 2017-07-18 | 2020-05-27 | DDP Specialty Electronic Materials US, Inc. | A method for biofilm dispersal |
MX2021007529A (es) * | 2018-12-26 | 2021-08-05 | Colgate Palmolive Co | Metodo de visualizacion para analizar el crecimiento de la biopelicula bucal. |
CN115043891B (zh) * | 2022-05-11 | 2023-09-15 | 福建师范大学 | 化合物及其制备方法和用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5811924B2 (ja) * | 1978-11-16 | 1983-03-05 | サンスタ−株式会社 | 口腔組成物 |
CH662925A5 (de) * | 1984-12-04 | 1987-11-13 | Biodyn Ag | Zahnschonender zusatzstoff fuer saccharosehaltige nahrungsmittel und getraenke. |
US7189351B2 (en) | 2001-10-25 | 2007-03-13 | Spherix Incorporated | D-tagatose as an anti-biofilm agent |
KR20060075868A (ko) | 2004-12-29 | 2006-07-04 | 황재관 | 신규 정족수 감지 저해제 |
US20070166242A1 (en) | 2005-12-19 | 2007-07-19 | Kross Robert D | Oral care product and method for the reduction of dental caries through inclusion of mannan and galactomannan polysaccharides in dentifrice formulations |
JP5906011B2 (ja) | 2010-09-21 | 2016-04-20 | 株式会社ロッテ | 口腔用組成物 |
JP2013010724A (ja) | 2011-06-30 | 2013-01-17 | Lotte Co Ltd | 口腔内細菌の増殖抑制剤 |
JP2016509025A (ja) * | 2013-02-14 | 2016-03-24 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | プロバイオティックアルギニン分解性口腔用組成物ならびにプロバイオティックアルギニン分解性口腔用組成物の製造方法および使用方法 |
-
2015
- 2015-09-22 US US14/860,813 patent/US10292993B2/en active Active
- 2015-09-22 KR KR1020167019725A patent/KR101870239B1/ko active IP Right Grant
- 2015-09-22 CN CN201580050473.5A patent/CN106794191A/zh active Pending
- 2015-09-22 WO PCT/KR2015/009948 patent/WO2016048007A1/ko active Application Filing
- 2015-09-22 KR KR1020177008824A patent/KR101951024B1/ko active IP Right Grant
-
2019
- 2019-03-26 US US16/364,422 patent/US20190224222A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US10292993B2 (en) | 2019-05-21 |
KR20160096716A (ko) | 2016-08-16 |
WO2016048007A1 (ko) | 2016-03-31 |
KR101870239B1 (ko) | 2018-06-22 |
US20160082023A1 (en) | 2016-03-24 |
KR20170038195A (ko) | 2017-04-06 |
KR101951024B1 (ko) | 2019-02-21 |
US20190224222A1 (en) | 2019-07-25 |
CN106794191A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276153B (en) | c1-inh preparations and methods for preventing and treating disorders associated with c1 esterase inhibitor deficiency | |
EP3411504A4 (en) | ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE-1 DIABETES | |
WO2016044463A3 (en) | Mk2 inhibitors and uses thereof | |
PL3577135T3 (pl) | Kompozycja farmaceutyczna do stosowania do leczenia lub zapobiegania chorobom związanym z c5 | |
SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
WO2015003816A3 (en) | Cystobactamides | |
WO2015015378A3 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
EP3681499A4 (en) | CONNECTIONS AS RAS INHIBITORS AND THEIR USE | |
MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
EP3231436A4 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
EP3103802A4 (en) | Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect | |
TN2018000057A1 (en) | Compounds useful for inhibiting ror-gamma-t. | |
PH12017500348A1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
WO2015179823A3 (en) | Lung localized inhibitors of alpha(v)beta 6 | |
EP3189849A4 (en) | Novel peptide for inhibiting fat accumulation, and pharmaceutical composition for preventing or treating obesity, comprising same | |
WO2016048007A8 (ko) | D-갈락토오스를 포함하는 쿼럼센싱 저해제 | |
IL266659B (en) | Fgfr4 inhibitor, pharmaceutical composition comprising it and use thereof | |
WO2015118407A3 (en) | Oligonucleotides and methods for inhibiting or reducing bacterial biofilms | |
EP3235808A4 (en) | Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same | |
WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
MY186523A (en) | Macrocyclic rip2 kinase inhibitors | |
EP3677267A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF TUMORS, METHOD AND USES THEREOF | |
GB201411581D0 (en) | Compounds inhibiting the enzyme monopolar spindle 1 kinase, pharmaceutical compositions and uses thereof | |
WO2016109361A3 (en) | 3-fluoro-benzonitrile inhibitors of 11-beta-hydroxylase | |
GB201519258D0 (en) | Newly identified wnt/beta-catenin signal transduction inhibitors and the use thereof in the treatment or prevention of diseases and conditions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15843713 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 20167019725 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15843713 Country of ref document: EP Kind code of ref document: A1 |